Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02620603

Ligand	Ligand name	Chain	PDB	Tanimoto
YE7	IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE	A	2P98	0.74
RMC	(2R)-2-({6-[BENZYL(METHYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)BUTAN-1-OL	A	1YGJ	0.72
BPG	9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE	A,B	1QHI	0.73
FR9	1-[(1R)-3-(6-{[(BENZYLAMINO)CARBONYL]AMINO}-1H-INDOL-1-YL)-1-(HYDROXYMETHYL)PROPYL]-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1O5R	0.7
GDV	(5R,6R,7R,8S)-8-(ACETYLAMINO)-6,7-DIHYDROXY-5-(HYDROXYMETHYL)-N-PHENYL-1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXAMIDE	A	2J47	0.72
XIH	2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE	A	2GBI	0.78
ABR	(R)-(N-PHENYL-2-HYDROXY-ETHYL)-2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE	A	1K5E	0.72
MGQ	7-BENZYL GUANINE MONOPHOSPHATE	A,E	2V8X	0.73
5HI	(3R,5R)-7-[2-(4-fluorophenyl)-4-{[(1S)-2-hydroxy-1-phenylethyl]carbamoyl}-5-(1-methylethyl)-1H-imidazol-1-yl]-3,5-dihydroxyheptanoic acid	A,B,C,D	3CCZ	0.73
RUN	2-[(1R,3S,4S)-1-BENZYL-4-[N-(BENZYLOXYCARBONYL)-L-VALYL]AMINO-3-PHENYLPENTYL]-4(5)-(2-METHYLPROPIONYL)IMIDAZOLE	B	1HPS	0.71
OLO	OLOMOUCINE	A	4ERK	0.72
OLO	OLOMOUCINE	C	1W0X	0.72
MGV	P-FLUORO-7-BENZYL GUANINE MONOPHOSPHATE	A,E	2V8Y	0.72
FR2	1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDW	0.77
FR7	1-{(1R,2S)-1-[2-(2,3,-DICHLOROPHENYL)ETHYL]-2-HYDROXYPROPYL}-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1V79	0.73
FR3	1-((1R)-1-(HYDROXYMETHYL)-3-(1-NAPHTHYL)PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDY	0.74
SC3	7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE	A,B,C,D	2AJ8	0.8
356	8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione	A,B	2RGU	0.71
FR6	1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}-1H-IMIDAZOLE-4-CARBOXAMIDE	A	2E1W	0.75
GRD	benzyl (S)-1-((2S,3S)-1-(3-(6-amino-9H-purin-9-yl)propylamino)-2-hydroxy-1-oxopentan-3-ylamino)-4-methyl-1-oxopentan-2-ylcarbamate	A	2R9C	0.77
PUY	PUROMYCIN	A,B	2DPT	0.7
PUY	PUROMYCIN	1,2,4,5,A,B,C,D,E,J,K,L,M,N,O,P,R,S,T,U,V,Z	1Q7Y	0.7
GSS		A	1AP1	0.75
FTB	N-{4-[1-(2-FLUOROBENZYL)-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL]-PHENYL}-ACETAMIDE	A	1NHX	0.74
VGB	(5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)-2-(2-phenylethyl)-8-(propanoylamino)-5,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyridin-4-ium	A,B	2WB5	0.71
TSX	N-[4-(1-ALLYL-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL)-PHENYL]-ACETAMIDE	A	1M51	0.76
GSR		A	1AF1	0.75
RRC	R-ROSCOVITINE	A,B,C,D	3DDQ	0.72
RRC	R-ROSCOVITINE	A	1YGK	0.72
RRC	R-ROSCOVITINE	A	1UNL	0.72
RRC	R-ROSCOVITINE	A	2A4L	0.72
4RB	4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid	A	3BQR	0.72
CAG		A	1GNQ	0.72
CAG		A	1PLJ	0.72
CAG		X	2EVW	0.72
CAG		A	1GNR	0.72
CAG		X	2CL6	0.72
CK9	2-{[(2-{[(1R)-1-(HYDROXYMETHYL)PROPYL]AMINO}-9-ISOPROPYL-9H-PURIN-6-YL)AMINO]METHYL}PHENOL	X	2A0C	0.75
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	2ALY	0.7
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	1VBM	0.7
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	1VBN	0.7
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	2PID	0.7
ABS	(S)-(N-PHENYL-2-HYDROXY-ETHYL)-2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE	A	1K5F	0.72
FRC	1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE	A	1V7A	0.7
GSZ	N-[(5R,6R,7R,8S)-6,7-DIHYDROXY-5-(HYDROXYMETHYL)-2-(2-PHENYLETHYL)-1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2-A]PYRIDIN-8-YL]-2-METHYLPROPANAMIDE	A,B	2J62	0.7
4HI	(3R,5R)-7-[4-(benzylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-1H-imidazol-1-yl]-3,5-dihydroxyheptanoic acid	B,C,D	3CCW	0.71
C12	2-(1-AMINO-2-HYDROXYPROPYL)-4-(4-HYDROXYBENZYL)-1-(2-OXOETHYL)-1H-IMIDAZOL-5-OLATE	A	2FZU	0.74